Lehman, Amy M.

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Dubovsky, J. A., Beckwith, K. A., Natarajan, G., Woyach, J. A., Jaglowski, S., Zhong, Y., Hessler, J. D., Liu, T.-M., Chang, B. Y., Larkin, K. M., et al. (2013) · Blood

Chronic Lymphocytic Leukemia ResearchT-cell and B-cell Immunology

Cited by 810

Targeting the C481S ibrutinib-resistance mutation in Bruton’s tyrosine kinase using PROTAC-mediated degradation

Buhimschi, A. D., Armstrong, H. A., Toure, M., Jaime-Figueroa, S., Chen, T. L., Lehman, A. M., Woyach, J. A., Johnson, A. J., Byrd, J. C., & Crews, C. M. (2018) · Biochemistry

Chronic Lymphocytic Leukemia ResearchProtein Degradation and Inhibitors

Cited by 394

PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression

Dong, S., Harrington, B. K., Hu, E. Y., Greene, J. T., Lehman, A. M., Tran, M., Wasmuth, R. L., Long, M., Muthusamy, N., Brown, J. R., et al. (2018) · Journal of Clinical Investigation

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 52

Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation: an analysis of the United Network of Organ Sharing registry

Hayes, D., Higgins, R. S., Black, S. M., Wehr, A. M., Lehman, A. M., Kirkby, S., & Whitson, B. A. (2015) · The Journal of Heart and Lung Transplantation

Transplantation: Methods and OutcomesPulmonary Hypertension Research and Treatments

Cited by 41

Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry

Hayes, D., Higgins, R. S., Kirkby, S., McCoy, K. S., Wehr, A. M., Lehman, A. M., & Whitson, B. A. (2014) · Journal of Cystic Fibrosis

Transplantation: Methods and OutcomesPulmonary Hypertension Research and Treatments

Cited by 35